140 related articles for article (PubMed ID: 1551698)
1. Graft-specific MHC class II gene expression in response to allogeneic stimulus in heterotopic murine cardiac allografts.
Xu R; Burdick JF; Scott A; Beschorner WE; Adler W; Kittur DS
Immunology; 1992 Feb; 75(2):361-5. PubMed ID: 1551698
[TBL] [Abstract][Full Text] [Related]
2. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
[TBL] [Abstract][Full Text] [Related]
3. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
[TBL] [Abstract][Full Text] [Related]
4. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
[TBL] [Abstract][Full Text] [Related]
5. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.
Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN
Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467
[TBL] [Abstract][Full Text] [Related]
6. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
7. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
[TBL] [Abstract][Full Text] [Related]
8. Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
Qian S; Fu F; Li Y; Gao L; Lu L; Noyola H; Rao AS; Thomson AW; Fung JJ
Immunology; 1995 May; 85(1):82-7. PubMed ID: 7635525
[TBL] [Abstract][Full Text] [Related]
9. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
10. The induction of class II antigens by interferon-gamma and its relevance for the acute rejection of allografts.
IJzermans JN; Bouwman E; de Bruin RW; Marquet RL; Jeekel J
Transplant Proc; 1987 Feb; 19(1 Pt 1):244-5. PubMed ID: 3152697
[No Abstract] [Full Text] [Related]
11. Survival of MHC-deficient mouse heterotopic cardiac allografts.
Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
[TBL] [Abstract][Full Text] [Related]
12. Prolonged survival of class II transactivator-deficient cardiac allografts.
June Brickey W; Felix NJ; Griffiths R; Zhang J; Wang B; Piskurich JF; Itoh-Lindstrom Y; Coffman TM; Ting JP
Transplantation; 2002 Nov; 74(9):1341-8. PubMed ID: 12451276
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection.
Forbes RD; Parfrey NA; Gomersall M; Darden AG; Guttmann RD
J Exp Med; 1986 Oct; 164(4):1239-58. PubMed ID: 3531383
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of MHC class II antigens in rejecting canine lung allografts.
Chang SC; Hsu HK; Perng RP; Shiao GM; Lin CY
Transplantation; 1990 Jun; 49(6):1158-63. PubMed ID: 2113727
[TBL] [Abstract][Full Text] [Related]
15. Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts.
Mannon RB; Doyle C; Griffiths R; Bustos M; Platt JL; Coffman TM
Transplantation; 2000 May; 69(10):2137-43. PubMed ID: 10852613
[TBL] [Abstract][Full Text] [Related]
16. Altered gene expression of cytokine, ICAM-1, and class II molecules precedes mouse intestinal allograft rejection.
Quan D; Grant DR; Zhong RZ; Zhang Z; Garcia BM; Jevnikar AM
Transplantation; 1994 Oct; 58(7):808-16. PubMed ID: 7940716
[TBL] [Abstract][Full Text] [Related]
17. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma alters the pathology of graft rejection: protection from early necrosis.
Halloran PF; Miller LW; Urmson J; Ramassar V; Zhu LF; Kneteman NM; Solez K; Afrouzian M
J Immunol; 2001 Jun; 166(12):7072-81. PubMed ID: 11390451
[TBL] [Abstract][Full Text] [Related]
19. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
[TBL] [Abstract][Full Text] [Related]
20. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
